Skip to content

Author

A. Pottegård

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

GLP-1 therapies and cancer risk.

Correct interpretation of evidence is essential in a rapidly evolving medical landscape.

B. Hicks, A. Pottegård · 0 citations
Oct 2026

Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Older Adults With Type 2 Diabetes: A Cohort Study.

OBJECTIVE Sodium-glucose cotransporter 2 inhibitors (SGLT2is) have demonstrated cardiorenal benefits in individuals with type 2 diabetes, but safety data in older adults remain limited. We evaluated the real-world safety of SGLT2is compared with dipeptidyl peptidase 4 inhibitors (DPP-4is) among individuals aged ≥75 yea...

Hanin Harbi, Michael Nesrallah, G. Carney et al. · 0 citations
Open access Aug 2026

Regional Variation in ADHD Treatment and Diagnosis Among Children and Adolescents in Denmark

Geographic variation in ADHD treatment and diagnosis among children and adolescents is well documented, yet the system‐level factors driving such differences remain poorly understood. We examined nationwide patterns of ADHD medication use and diagnoses in Denmark in 2024 and assessed whether municipal socioeconomy, reg...

H. Sonne, A. Pottegård, A. S. Hansen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.